|
Year
|
Title
|
Authors
|
Publication
|
|
2017
|
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
|
Schriber JR, Hari PN, Ahn KW, Fei M, Costa LJ, Kharfan-Dabaja MA, Angel-Diaz M, Gale RP, Ganguly S, Girnius SK, Hashmi S, Pawarode A, Vesole DH, Wiernik PH, Wirk BM, Marks DI, Nishihori T, Olsson RF, Usmani S, Mark TM, Nieto YL, D'Souza A
|
Cancer 123(16):3141-3149
|
|
2017
|
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: A CIBMTR analysis.
|
|
Br J Haematol
|
|
2017
|
Risk factors for subsequent central nervous system tumors in pediatric allogeneic hematopoietic cell transplant: A study from the Center for International Blood and Marrow Transplant Research.
|
Gabriel M, Shaw B, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li C-K, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw P
|
Biol Blood Marrow Transplant 23(8):1320-1326
|
|
2017
|
Umbilical cord blood transplantation in children with acute leukemia: Impact of conditioning on transplant outcomes.
|
Eapen M, Kurtzberg J, Zhang M-J, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE
|
Proc Natl Acad Sci U S A
|
|
2017
|
Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States.
|
Muffly L, Pasquini M, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn J-Y, Carabasi M, Chen Y-B, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror M, Szer J, Wirk BM, Wood WA, Artz A
|
Blood
|
|
2017
|
Fast and accurate HLA typing from short-read next-generation sequence data with xHLA.
|
Xie C, Yeo ZX, Wong M, Piper J, Long T, Kirkness EF, Biggs WH, Bloom K, Spellman S, Vierra-Green C, Brady C, Scheuermann RH, Telenti A, Howard S, Brewerton S, Turpaz Y, Venter JC
|
Proc Natl Acad Sci U S A
|
|
2017
|
Response assessment in myeloma: practical manual on consistent reporting in an era of dramatic therapeutic advances.
|
Garderet L, D'Souza A, Jacobs P, van Biezen A, Schönland S, Kroeger N, Morris C, Hari P
|
Biol Blood Marrow Transplant 23(7):1193-1202
|
|
2017
|
KIR3DL1/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation.
|
Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le LuduecJ-B, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H, Reed EF, Yu N, Vierra-Green C, Haagenson M, Malkki M, Petersdorf EW, Spellman S, Hsu K
|
J Clin Oncol 35(20):2268-2278
|
|
2017
|
HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities.
|
Fleischhauer K, Shaw BE
|
Blood
|
|
2017
|
Parent versus Child Donor Perceptions of the Bone Marrow Donation Experience.
|
Switzer GE, Bruce J, Pastorek G, Kiefer DM, Kobusingye H, Drexler R, Besser RAM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Weiner L, Packman W, Varni JW, Pulsipher MA
|
Bone Marrow Transplant
|
|
2017
|
Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant cyclophosphamide.
|
Bashey A, Zhang M-J, McCurdy SR, St, Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales M-A, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M
|
J Clin Oncol
|
|
2017
|
Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014.
|
D'Souza A, Zhang M-J, Huang J, Fei M, Pasquini M, Hamadani M, Hari P
|
Leukemia
|
|
2017
|
Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.
|
Eapen M, Wang T, Veys PA, Boelens JJ, St, Martin A, Spellman S, Bonfim C, Brady C, Cant AJ, Dalle J-H, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris M, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A
|
Lancet Haematol
|
|
2017
|
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma.
|
Epperla N, Ahn KW, Ahmed S, Jagasia M, DiGilio A, Devine SM, Jaglowski S, Kennedy V, Rezvani AR, Smith SM, Sureda A, Fenske TS, Kharfan-Dabaja MA, Armand P, Hamadani M
|
J Hematol Oncol 10(1):117
|
|
2017
|
Current use and trends in hematopoietic cell transplantation in the United States.
|
D'Souza A, Lee S, Zhu X, Pasquini M
|
Biol Blood Marrow Transplant
|
|
2017
|
Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.
|
Fleischhauer K, Ahn KW, Wang HL, Zito L, Crivello P, Müller C, Verneris M, Shaw BE, Pidala J, Oudshorn M, Lee SJ, Spellman SR
|
Bone Marrow Transplant
|
|
2017
|
Outcomes of UCB transplantation are comparable in FLT3+ AML: Results of CIBMTR, eurocord and EBMT collaborative analysis.
|
Ustun C, Giannotti F, Zhang M-J, Wang H-L, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier B, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A
|
Leukemia 31(6):1408-1414
|
|
2017
|
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.
|
Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang M-J, Eapen M
|
Cancer 123(11):2025-2034
|
|
2017
|
Outcomes after umbilical cord blood transplantation for myelodysplastic syndromes.
|
Gerds AT, Woo Ahn K, Hu ZH, Abdel-Azim H, Akpek G, Aljurf M, Ballen KK, Beitinjaneh A, Bacher U, Cahn J-Y, Chharbra S, Cutler C, Daly A, DeFilipp Z, Gale RP, Gergis U, Grunwald MR, Hale GA, Hamilton BK, Jagasia M, Kamble RT, Kindwell-Keller T, Nishihori T, Olsson RF, Ramanathan M, Saad AA, Solh M, Ustun C, Valcárcel D, Warlick E, Wirk BM, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W
|
Biol Blood Marrow Transplant 23(6):971-979
|
|
2017
|
Revealing complete complex KIR haplotypes phased by long-read sequencing technology.
|
Roe D, Vierra-Green C, Pyo C-W, Eng K, Hall R, Kuang R, Spellman S, Ranade S, Geraghty DE, Maiers M
|
Genes Immun
|
|
2017
|
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
|
Michelis FV, Gupta V, Zhang M-J, Wang H-L, Aljurf M, Bacher U, Beitinjaneh A, Chen Y-B, DeFilipp Z, Gale RP, Kebriaei P, Kharfan-Dabaja M, Lazarus HM, Nishihori T, Olsson RF, Oran B, Rashidi A, Rizzieri DA, Tallman MS, de Lima M, Khoury HJ, Sandmaier BM, Weisdorf D, Saber W
|
Cancer 123(11):2035-2042
|
|
2017
|
Healthcare costs and utilization for patients age 50-64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation
|
Preussler JM, Meyer CL, Mau L-W, Majhail NS, Denzen E, Edsall KC, Farnia SH, Saber W, Burns LJ, Vanness DJ
|
Biol Blood Marrow Transplant 23(6):1021-1028
|
|
2017
|
Investigating the association of genetic admixture and donor/recipient genetic disparity with transplant outcomes.
|
Madbouly A, Wang T, Haagenson M, Paunic V, Vierra-Green C, Fleischhauer K, Hsu KC, Verneris MR
|
Biol Blood Marrow Transplant 23(6):1029-1037
|
|
2017
|
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
|
El-Jawahri A, Chen Y-B, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz M-A, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W
|
Cancer 123(10):1828-1838
|
|
2017
|
Tools for the precision medicine era: How to develop highly personalized treatment recommendations from cohort and registry data using Q-learning.
|
Krakow EF, Hemmer M, Wang T, Logan B, Arora M, Spellman S, Couriel D, Alousi A, Pidala J, Last M, Lachance S, Moodie EEM
|
Am J Epidemiol
|
|
2017
|
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.
|
Brunstein C, Zhang M-J, Barker J, St, Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M
|
Haematologica 102(5):941-947
|
|
2017
|
National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
|
Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers MED, Gajewski J, Gastineau D, Greenwald M, Jagasia M, Martin P, Rizzo JD, Schmit-Pokorny K, Majhail NS
|
Biol Blood Marrow Transplant 23(5):717-725
|
|
2017
|
Improved survival after acute graft vs. host disease diagnosis in the modern era.
|
Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn J-Y, Cairo M, Chen Y-B, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socié G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hermatti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J
|
Haematologica 102(5):958-966
|
|
2017
|
Allogeneic hematopoietic cell transplantation for aggressive NK cell leukemia. A Center for International Blood and Marrow Transplant Research analysis.
|
Hamadani M, Kanate AS, DiGilio A, Ahn KW, Smith SM, Lee JW, Ayala E, Chao N, Hari P, Bolaños-Meade J, Gress R, Smedegaard Anderson N, Chen Y-B, Farooq U, Schiller G, Yared J, Sureda A, Fenske TS, Olteanu H
|
Biol Blood Marrow Transplant 23(5):853-856
|
|
2017
|
Survival and late effects after allogeneic hematopoietic cell transplantation for hematologic malignancy at less than three years of age.
|
Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C
|
Biol Blood Marrow Transplant
|
|
2017
|
Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
|
Segal E, Martens M, Wang HL, Brazauskas R, Weisdorf D, Sandmaier BM, Khoury HJ, de Lima M, Saber W
|
Cancer
|
|
2017
|
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.
|
Pappas DJ, Lizee A, Paunic V, Beutner KR, Motyer A, Vukcevic D, Leslie S, Biesiada J, Meller J, Taylor KD, Zheng X, Zhao LP, Gourraud P-A, Hollenbach JA, Mack SJ, Maiers M
|
Pharmacogenomics J
|
|
2017
|
Hematopoietic stem cell transplant activity in pediatric cancer between 2008 and 2014 in the United States: a CIBMTR report.
|
Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA
|
Biol Blood Marrow Transplant
|
|
2017
|
Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.
|
Syrjala KL, Sutton SK, Jim HS, Knight JM, Wood WA, Lee SJ, Jacobsen PB, Abidi MH, Yi JC
|
Cancer 123(8):1416-1423
|
|
2017
|
Instrumental variable with competing
risk model.
|
Zheng C, Dai R, Hari PN, Zhang M-J
|
Stat Med 36(8):1240-1255
|
|
2017
|
Myeloablative vs. reduced intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
|
Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick E, Fernandez HF, Alyea E, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal A, Horowitz MM, Deeg HJ, Horwitz ME
|
J Clin Oncol 35(11):1154-1161
|
|
2017
|
Outcome of hematopoietic cell transplantation for DNA-double strand breakage repair disorders.
|
Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Büchner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Heminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora K-W, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR
|
J Allergy Clin Immunol
|
|
2017
|
East meets west - impact of ethnicity on donor match rates in the Ezer Mizion Bone Marrow Donor Registry.
|
Halagan M, Manor S, Shriki N, Yaniv I, Zisser B, Madbouly A, Maiers M, Stein J
|
Biol Blood Marrow Transplant
|
|
2017
|
Relative telomere length prior to hematopoietic cell transplantation (HCT) and outcome after unrelated donor HCT for acute leukemia.
|
Wang Y, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Lee SJ, Savage SA, Gadalla SM
|
Biol Blood Marrow Transplant
|
|
2017
|
Long-term outcome of inflammatory breast cancer compared to non-inflammatory breast cancer in the setting of high-dose chemotherapy with autologous hematopoietic cell transplantation.
|
Cheng YC, Shi Y, Zhang M-J, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayashi L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N
|
J Cancer 8(6):1009-1017
|
|
2017
|
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
|
Kekre N, Zhang Y, Zhang M-J, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee J-W, Nakamura R, Pulsipher MA, Eapen M, Antin JH
|
Haematologica
|
|
2017
|
Sickle cell disease: An international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
|
Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle J-H, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M
|
Blood 129(11):1548-1556
|
|
2017
|
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
|
Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ
|
Biol Blood Marrow Transplant 23(3):367-378
|
|
2017
|
GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.
|
Chen Y-B, Wang T, Hemmer MT, Brady C, Couriel DR, Alousi A, Pidala J, Urbano-Isizua A, Choi SW, Nishihori T, Teshima T, Inamoto Y, Wirk B, Marks DI, Abdel-Azim H, Lehmann L, Yu L, Bitan M, Cairo MS, Qayed M, Salit R, Gale RP, Martino R, Jaglowski S, Bajel A, Savani B, Frangoul H, Lewis ID, Storek J, Askar M, Kharfan-Dabaja MA, Aljurf M, Ringen O, Reshef R, Olsson RF, Hashmi S, Seo S, Spitzer TR, MacMillan ML, Lazaryan A, Spellman SR, Arora M, Cutler CS
|
Bone Marrow Transplant 52(3):400-408
|
|
2017
|
MHC class I chain-related gene A (MICA) donor-recipient mismatches and MICA-129 polymorphism in unrelated donor hematopoietic cell transplantations has no impact on outcomes in acute lymphoblastic leukemia, acute myeloid leukemia, or myelodysplastic syndrome: A Center for International Blood and Marrow Transplant Research study.
|
Askar M, Sobecks R, Wang T, Haagenson M, Majhail N, Madbouly A, Thomas D, Zhang A, Fleischhauer K, Hsu K, Verneris M, Lee SJ, Spellman SR, Fernández-Viña M
|
Biol Blood Marrow Transplant 23(3):436-444
|
|
2017
|
Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis.
|
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnĕný M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R
|
JAMA Neurol
|
|
2017
|
HLA amino acid polymorphisms and kidney allograft survival.
|
Kamoun M, McCullough KP, Maiers M, Fernandez Vina MA, Li H, Teal V, Leichtman AB, Merion RM
|
Transplantation 101(5):e170-e177
|
|
2017
|
Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation.
|
Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ, Verneris MR, Hsu K, Fleischhauer K, Cutler C, Antin JH, Neuberg D, Ebert BL
|
N Engl J Med 376(6):536-547
|
|
2017
|
Maintenance versus induction therapy choice on outcomes after autologous transplantation for multiple myeloma.
|
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang M-J, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P
|
Biol Blood Marrow Transplant 23(2):269-277
|
|
2017
|
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.
|
Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee J-W, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML
|
Bone Marrow Transplant 52(2):270-278
|
|
2017
|
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
|
DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE
|
Bone Marrow Transplant 52(2):173-182
|
|
2017
|
Allogeneic hematopoietic cell transplant for adult chronic myelomonocytic leukemia.
|
Liu HD, Ahn KW, Hu Z-H, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Aljurf M, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwell-Keller T, Akpek G, Savani BN, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W
|
Biol Blood Marrow Transplant
|
|
2017
|
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.
|
Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW
|
Blood 129(2):162-170
|
|
2017
|
Novel HLA-DP region susceptibility loci associated with severe acute GvHD.
|
Goyal RK, Lee SJ, Wang T, Trucco M, Haagenson M, Spellman SR, Verneris M, Ferrell RE
|
Bone Marrow Transplant 52(1):95-100
|
|
2017
|
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group report.
|
Shaw BE, Hahn T, Martin PJ, Mitchell SA, Petersdorf EW, Armstrong GT, Shelburne N, Storer BE, Bhatia S
|
Biol Blood Marrow Transplant 23(1):10-23
|
|
2017
|
Health-related quality of life among older related hematopoietic stem cell donors (>60 years) is equivalent to that of younger related donors (18 to 60 years): A related donor safety study.
|
Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA
|
Biol Blood Marrow Transplant 23(1):165-171
|
|
2017
|
Allogeneic transplantation for relapsed Waldenström macroglobulinemia and lymphoplasmacytic lymphoma.
|
Cornell RF, Bachanova V, D'Souza A, Woo-Ahn K, Martens M, Huang J, Al-Homsi AS, Chhabra S, Copelan E, Diaz M-A, Freytes CO, Gale RP, Ganguly S, Hamadani M, Hildebrandt G, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Saad A, Usmani S, Vesole DH, Yared J, Mark T, Nieto Y, Hari P
|
Biol Blood Marrow Transplant 23(1):60-66
|
|
2017
|
Limited HLA sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor-recipient pairs.
|
Hou L, Vierra-Green C, Lazaro A, Brady C, Haagenson M, Spellman S, Hurley CK
|
HLA 89(1):39-46
|
|
2017
|
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.
|
Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S
|
Bone Marrow Transplant 52(1):59-65
|
|
2017
|
Pretransplantation exercise and hematopoietic cell transplantation survival: A secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902).
|
Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ
|
Biol Blood Marrow Transplant 23(1):161-164
|
|
2017
|
Recipient HLA-C haplotypes and microRNA 148a/b binding sites have no impact on allogeneic hematopoietic cell transplantation outcomes.
|
Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR
|
Biol Blood Marrow Transplant 23(1):153-160
|
|
2017
|
Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia.
|
Rosko AE, Wang H-L, de Lima M, Sandmaier B, Khoury HJ, Artz A, Brammer J, Bredeson C, Farag S, Kharfan-Dabaja M, Lazarus HM, Marks DI, Martino Bufarull R, McGuirk J, Mohty M, Nishihori T, Nivison-Smith I, Rashidi A, Ringden O, Seftel M, Weisdorf D, Bachanova V, Saber W
|
Am J Hematol 92(1):42-49
|
